Mar 12, 2009 by Robert SteyerA Valeant EffortThe constantly changing drugmaker tries another strategy.
Mar 3, 2009 by Robert SteyerSeeking Gain From Pain King Pharmaceuticals tries to remake itself as a pain therapy company.
Mar 2, 2009 by Robert SteyerCasinos: Still a Bad BetThe casino industry serves up more unsettling news.
Feb 26, 2009 by Robert SteyerMerck KGaA's Good ChemistryThis German conglomerate successfully mixes drugs and chemicals.
Feb 13, 2009 by Robert SteyerBetting on Bet TechGambling equipment makers try to soften the slump that's slamming their casino customers.
Feb 10, 2009 by Robert SteyerRx for a Drug Deal?Will circumstance and psychology prod Sanofi-Aventis into a big acquisition?
Feb 9, 2009 by Robert SteyerJust Say No to Drug Company MergersThere's more to big-pharma megamergers than meets the eye.
Feb 4, 2009 by Robert SteyerCasinos Can't Avoid Falling ChipsDecreased spending makes casino companies look like a bad bet.
Feb 3, 2009 by Robert SteyerAn Emerging Medical PowerAustralia's CSL uses technology and acquisitions to expand its influence.
Jan 27, 2009 by Robert SteyerAnother Angle for Fibromyalgia In the past 18 months, the FDA has approved three drugs that can be used to treat the disease.
Jan 23, 2009 by Robert SteyerBAX to the FutureAfter minding its own business, Baxter International starts thinking about acquisitions again.
Jan 15, 2009 by Robert SteyerFor Pfizer, a Big Buy Could Be a Big MistakeWhy the big pharma shouldn't bet the ranch.
Jan 15, 2009 by Robert SteyerMedicis Tries to Save FaceThe drugmaker hopes it can smooth out a tough economy.
